Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Cohort 1: hatg, csa, epag day 14 to month 6	Antilymphocyte immunoglobulin (horse)	[1] D08808 💬	-	-	[1] 60 💬
2	Cohort 2: hatg, csa, epag day 14 to month 3	Antilymphocyte immunoglobulin (horse)	[1] D08808 💬	-	-	[1] 60 💬
3	Cohort 3: hatg, csa (dose reduced), epag day 1 to month 6	Antilymphocyte immunoglobulin (horse)	[1] D08808 💬	-	-	[1] 60 💬
4	Enalapril	Enalapril	[2] D00621, D07892 💬	[1] ACE 💬	[6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system	[7] 19, 46, 66, 113, 210, 222, 223 💬
5	Enalapril and other angiotensin converting enzyme inhibitors	Angiotensin II	[4] D00150, D00621, D02014, D07892 💬	[3] ACE, AGTR1, AGTR2 💬	[18] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	[1] 19 💬
6	Enalapril maleate	Enalapril	[2] D00621, D07892 💬	[1] ACE 💬	[6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system	[1] 46 💬
7	Enalapril valsartan methylprednisone	Enalapril	[3] D00400, D00621, D07892 💬	[2] ACE, AGTR1 💬	[18] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	[1] 66 💬
8	Epa	-	-	-	-	[6]  8 , 46, 48, 49, 113, 301 💬
9	Epa and dha	-	-	-	-	[1] 113 💬
10	Epa and dha supplementation	-	-	-	-	[2] 48, 49 💬
11	Epadel	-	-	-	-	[1] 296 💬
12	Epanova	-	-	-	-	[1] 96 💬
13	Epanova™ (omega-3 free fatty acids)	Omega-3 fatty acids	-	-	-	[1] 96 💬
14	Eparmefolin 30 cpr 0,1/0,5mg	-	-	-	-	[1] 13 💬
15	Epatuzumab	-	-	-	-	[1] 49 💬
16	Epax 6000 ee 1000mg (0.6 gr dha+epa)	-	-	-	-	[1] 46 💬
17	Epaxal	-	-	-	-	[1] 46 💬
18	Epaxal berna (virosomal hepatitis a vaccine)	Hepatitis A Vaccine	-	-	-	[2] 96, 97 💬
19	Ethyl-epa	Icosapent ethyl	[1] D01892 💬	-	-	[1]  8  💬
20	Ethyl-epa (miraxion™)	Icosapent ethyl	[1] D01892 💬	-	-	[1]  8  💬
21	Hepatitis a vaccine ( havrix or epaxal)	Hepatitis A Vaccine	-	-	-	[1] 46 💬
22	Over the counter dha/epa dietary supplementation	-	-	-	-	[1] 301 💬

Back to top